Advanced Search

Preventive Medicine Evaluations

To view Evaluated Articles, you must have an active subscription (or trial) and be signed in.
If you have an active subscription (or trial), please sign in. If your access has expired, you can subscribe at $9.95 per month. If you think you should be able to access this content, please contact us.

Sign in | Free Trial | Subscribe | Recommend to Library

New to F1000? See the Top Rated article below for a free preview of one of our Evaluated Articles.

SECTION HEADS

  • Photo of Robert Hiatt

    Robert Hiatt

    Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA

Section Topics

  • » Interventions: behavior change
  • » Interventions: chemoprevention
  • » Interventions: legislation
  • » Interventions: screening
  • » Interventions: vaccination
  • » Modifiable risk factors: alcohol
  • » Modifiable risk factors: diet & nutrition
  • » Modifiable risk factors: drugs
  • » Modifiable risk factors: hypertension
  • » Modifiable risk factors: obesity
  • » Modifiable risk factors: sedentary lifestyle
  • » Modifiable risk factors: smoking
  • » Preventable diseases: cancer
  • » Preventable diseases: cardiovascular disease
  • » Preventable diseases: infectious diseases
  • » Preventable diseases: injury control
  • » Preventable diseases: metabolic & nutritional disorders
  • » Preventable diseases: oral disease
  • » Preventable diseases: psychiatric disorders

LATEST EVALUATION

This study demonstrates the importance of colonoscopy and surveillance in the prevention of the development of colon cancer. In this prospectively designed study, which was performed in the 1980s, the authors demonstrate that polypectomy during...

Joseph Pisegna, University of California, Los Angeles, USA. F1000 Pharmacology & Drug Discovery

8 Must Read

TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]

16
Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths.

Zauber AG, Winawer SJ, O'Brien MJ, Lansdorp-Vogelaar I, ..., Schapiro M, Panish JF, Stewart ET, Waye JD. N Engl J Med. 2012 Feb 23; 366(8):687-96

5 Evaluations, most recent by

Joseph Pisegna, University of California, Los Angeles, USA. F1000 Pharmacology & Drug Discovery

  • New Finding
  • Good for Teaching
  • Confirmation
  • Controversial

INDIVIDUALS

Get instant access to evaluations from over 10,000 experts in biology and medicine by taking a free trial or an individual subscription.

Get a FREE Trial Subscribe for $9.95 per month

Already have a subscription? Sign in for instant access. If you are signed in but are not able to view content, your access has expired. Please take out a subscription or recommend F1000 to your librarian.

RECOMMENDATIONS

Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.

Recommend to your Librarian

LIBRARIANS & INFORMATION MANAGERS

Get an extended free trial supporting clinicians and researchers at your academic or corporate institution.

Request an Institutional Trial

FREE ACCESS

Your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.

Faculty of 1000